Fresenius Medical Care Annual General Meeting: Strengthening Performance and Advancing Innovation in Kidney Care
May 22, 2026
May 22, 2026
HOMBURG, Germany, May 22 -- Fresenius Medical Care, a provider of products and services for people with chronic kidney failure, issued the following news release on May 21, 2026:
* * *
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
* Shareholders approve proposed dividend of EUR 1.49 per share
FME Reignite strategy launched in 2025 successfully drives the next phase of value crea . . .
* * *
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
* Shareholders approve proposed dividend of EUR 1.49 per share
FME Reignite strategy launched in 2025 successfully drives the next phase of value crea . . .
